| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.024 | 0.9 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | 0.019 | 0.9 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.0088 | 0.9 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.9 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.0054 | 0.9 |